The President of Oxford University Vaccines Andrew Pollard revealed that the vaccines for dealing with new variants of the virus will be ready as early as next September, explaining that even the current vaccines will provide some protection against these strains, stressing that the epidemic simply will not be widespread compared to the past few months. .
According to a report by the British newspaper "Daily Mail", the Oxford expert confirmed that vaccines are the way out of the never-ending closures. Professor Pollard, director of the Oxford Vaccine Group and chief researcher of the Oxford vaccine trial, praised the public for receiving large quantities of vaccines, and said: " The greatest danger to humanity is not to vaccinate people, to face the greatest danger, which is the virus. "
The professor of childhood infection and immunology at the University of Oxford pointed out that the main question now is whether vaccines will work against variants such as mutations in South Africa and India, and he added: “I do not imagine that vaccines will be 100% effective, but they may significantly reduce the risk of disease. Serious even with variables. "
Professor Pollard expected that the updated vaccines to protect against the South African variant and other new variants are likely to be available by September or October, explaining that the main thing is to change the spike protein sequence to match some of the new variants.
Professor Pollard said, "I am optimistic to say that well-studied vaccines have protection for at least six months, and after a year we do not have any data. Really I am optimistic because the immune responses are so strong that they will continue beyond the six-month period."
Comments
Post a Comment